Ignite Creation Date:
2025-12-25 @ 12:39 AM
Ignite Modification Date:
2025-12-25 @ 10:49 PM
Study NCT ID:
NCT05077267
Status:
COMPLETED
Last Update Posted:
2024-09-27
First Post:
2021-10-11
Is NOT Gene Therapy:
False
Has Adverse Events:
True
Brief Title:
ABNCoV2 Vaccine in SARS-CoV-2 (COVID-19) Seronegative and Seropositive Adult Subjects
Sponsor:
Bavarian Nordic
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2021-08-19
Start Date Type:
ACTUAL
Primary Completion Date:
2022-02-02
Primary Completion Date Type:
ACTUAL
Completion Date:
2023-10-31
Completion Date Type:
ACTUAL
First Submit Date:
2021-10-11
First Submit QC Date:
None
Study First Post Date:
2021-10-14
Study First Post Date Type:
ACTUAL
Results First Submit Date:
2024-06-13
Results First Submit QC Date:
None
Results First Post Date:
2024-09-27
Results First Post Date Type:
ACTUAL
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2024-06-13
Last Update Post Date:
2024-09-27
Last Update Post Date Type:
ACTUAL